Atea Pharmaceuticals, Inc. (AVIR) › Shareholders' EquityAtea Pharmaceuticals, Inc. (AVIR) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$27.51M2018: -$36.16M2019: -$49.57M2020: $547.80M2021: $710.08M2022: $640.57M2023: $555.19M2024: $438.87M2025: $275.43M$275.43M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$275.43M-37.2%2024$438.87M-21.0%2023$555.19M-13.3%2022$640.57M-9.8%2021$710.08M+29.6%2020$547.80M+1205.1%2019-$49.57M-37.1%2018-$36.16M-31.4%2017-$27.51M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share